A Closer Look at MS Scans May Show Early Treatment Changes

Credibility

Interest

Share:2 min read

Key Takeaway

A detailed type of MS scan detected changes in brain tissue about three months after treatment began, but it is not yet clear whether those changes mean patients will feel or function better.

What They Found

Researchers used a special MRI scan that looks at how water moves through brain tissue, giving them a closer look than a standard scan. In people with relapsing MS who had not started treatment, some brain tissue that looked normal on scans showed signs of fiber changes and extra space around cells. MS spots, also called lesions, showed more tissue changes than nearby tissue that looked normal. About three months after 13 people started a strong MS treatment, their lesions showed scan changes that may reflect healthier fibers and fewer cells linked to inflammation. The researchers also found four patterns among lesions, including a pattern linked to active inflammation that was more common in relapsing MS.

Who Should Care and Why

People with MS and their caregivers may find this useful because a spot on a standard MRI does not tell the whole story of what is happening inside it. This scan works a bit like looking inside a wall rather than judging it only by its surface. For people starting treatment, it may one day help care teams see early tissue changes, even when daily symptoms have not clearly changed. Healthcare providers may also learn more about why lesions differ between people with relapsing MS and those whose disease is no longer relapsing. For now, keep using your usual appointments, symptoms, and standard scans to discuss treatment decisions with your MS care team.

Important Considerations

The study was small, with 37 people in the first scan and only 13 scanned again after treatment. Because everyone rescanned had started treatment, the study cannot prove that treatment alone caused the changes. The scan findings were not shown to predict better symptoms or less disability, so patients should not use them as a measure of personal recovery.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Treatment Updates Clinical Trials MS Progression

Article Topics:

diffusion MRImultiple sclerosiswhite matter lesion

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of clinical and translational neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News